Search results for "Cessation"

showing 10 items of 144 documents

Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age

2013

The aim of this study was to assess the effects of the antidepressant bupropion on anxiety and novelty-seeking in adolescent mice of different ages and adults. Behavioural differences between early adolescent, late adolescent and adult NMRI mice were measured both in the elevated plus-maze and the hole-board tasks following acute administration of bupropion (5, 10, 15, 20 mg/kg) or saline. In the plus maze test, early and late adolescent mice treated with bupropion (10, 15 mg/kg, respectively) had lower percentages of entries in the open-arms compared to their vehicle controls. Adult mice treated with bupropion did not differ from their vehicle controls. These results suggest that the effec…

MaleAgingmedicine.medical_specialtyElevated plus mazeHole-boardDEFICIT HYPERACTIVITY DISORDERmedicine.medical_treatmentAnxietySUBSTANCE USE DISORDERSINDIVIDUAL-DIFFERENCESHOLE-BOARD TESTMiceBehavioral NeuroscienceADULT RATSInternal medicinemedicineAnimalsSOCIAL-BEHAVIORMaze LearningPsychiatryBupropionBupropionHole-board testDose-Response Relationship DrugLOCOMOTOR-ACTIVITYNovelty seekingELEVATED PLUS-MAZEGeneral MedicineSMOKING-CESSATIONNICOTINE DEPENDENCEAdolescenceEndocrinologyNovelty-seekingAnxiogenicExploratory BehaviorAntidepressive Agents Second-GenerationSmoking cessationAntidepressantAnxietyAnimal Science and Zoologymedicine.symptomPsychologypsychological phenomena and processesmedicine.drugBehavioural Processes
researchProduct

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease : results from the EUROASPIRE IV …

2018

Background: This study aims to assess the cost-effectiveness of optimized guideline adherence in patients with a history of coronary heart disease. Methods: An individual-based decision tree model was developed using the SMART risk score tool which estimates the 10-year risk for recurrent vascular events in patients with manifest cardiovascular disease (CVD). Analyses were based on the EUROASPIRE IV survey. Outcomes were expressed as an incremental cost-effectiveness ratio (ICER). Results: Data from 4663 patients from 13 European countries were included in the analyses. The mean estimated 10-year risk for a recurrent vascular event decreased from 20.13% to 18.61% after optimized guideline a…

MaleCardiac & Cardiovascular SystemsCost effectivenessmedicine.medical_treatmentCost-Benefit AnalysisCoronary DiseaseDisease030204 cardiovascular system & hematology0302 clinical medicineOlder patientsMedicine030212 general & internal medicineguidelinesEUROASPIRE1102 Cardiorespiratory Medicine and Haematologyhealth care economics and organizationsBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina.Framingham Risk ScoreSecondary preventionASSOCIATIONMiddle AgedhumanitiesCoronary heart diseaseEuropeDENSITY-LIPOPROTEIN CHOLESTEROLPractice Guidelines as TopicTRIALFemaleGuideline AdherenceCardiology and Cardiovascular MedicineLife Sciences & Biomedicinesecondary prevention ; guidelines ; cost-effectiveness ; coronary heart disease ; EUROASPIREsecondary preventionmedicine.drugINTERVENTIONSmedicine.medical_specialtyEZETIMIBEGuidelinesEVENTS03 medical and health sciencesEzetimibeInternal medicineHumansIn patientcoronary heart diseaseBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine.cost-effectivenessMETAANALYSISAgedScience & Technologybusiness.industryDecision TreesSMOKING-CESSATIONCoronary heart diseaseTHRESHOLDSCardiovascular System & HematologyCardiovascular System & CardiologySmoking cessationCost-effectivenessbusinessSTATIN TREATMENT
researchProduct

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

2018

It is judged safe to discontinue treatment with tyrosine kinase inhibitors (TKI) for chronic myeloid leukemia (CML) in experimental trials on treatment-free remission (TFR). We collected a total of 293 Italian patients with chronic phase CML who discontinued TKI in deep molecular response. Seventy-two percent of patients were on treatment with imatinib, and 28% with second generation TKI at the time of discontinuation. Median duration of treatment with the last TKI was 77 months [Interquartile Range (IQR) 54;111], median duration of deep molecular response was 46 months (IQR 31;74). Duration of treatment with TKI and duration of deep molecular response were shorter with second generation TK…

MaleImatinib mesylate discontinuation; chronic myelogenous leukemia; treatment-free remission; long-term outcomes; molecular response; cml patients; recommendations; management; dasatinib; cessationchemistry.chemical_compound0302 clinical medicineTreatment Free RemissionPregnancyMED/15 - MALATTIE DEL SANGUEInterquartile rangeingleseMedicinedasatinibChronic Myelogenous Leukemiatreatment-free remissionPonatinibmolecular responseHematologyMiddle AgedProtein-Tyrosine Kinasescml patientsDasatinibTreatment OutcomeLeukemia Myeloid Chronic-PhaseDisease ProgressionImatinib MesylateFemaleChronic Myelogenous Leukemia; Discontinuation; Treatment Free Remissionlong-term outcomesmanagementmedicine.drugAdultmedicine.medical_specialtyChronic Myeloid LeukemiaSocio-culturaleDiscontinuationArticletyrosine kinase inhibitors discontinued treatment chronic myeloid leukemia treatment-free remission (TFR)Safety-Based Drug Withdrawals03 medical and health scienceschronic myeloid leukemia tyrosine kinase inhibitors discontinuationMedian follow-upLeukemia Myelogenous Chronic BCR-ABL PositiveInternal medicineImatinib mesylate discontinuationHumansProtein Kinase InhibitorsRetrospective Studiesbusiness.industryImatinibmedicine.diseaseDiscontinuationrespiratory tract diseasesSettore MED/15 - MALATTIE DEL SANGUEcessationNilotinibchemistryrecommendationsbusiness030215 immunologyChronic myelogenous leukemia
researchProduct

Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease.

2011

International audience; OBJECTIVE: Analysis of the leukocyte transriptome, in particular the Finkel-Biskis-Jinkins Osteosarcoma (c-Fos) gene, which has a prominent role in inflammation, provides new insights into atherosclerosis mechanisms. Although smoking is a major risk factor, the links between smoking status and coronary artery disease (CAD) remains unclear. We aimed to analyze the relationship between smoking status and c-Fos expression in circulating leukocytes of patients with CAD. METHODS: c-Fos expression was measured by RT-Q-PCR, from blood leukocytes of 239 consecutive patients after acute myocardial infarction (MI). The patients were asked about their smoking status and stratif…

MaleMESH : RNA MessengerMESH: Chi-Square DistributionMESH : LeukocytesMESH : Prospective StudiesMESH : AgedMyocardial InfarctionSmoking PreventionMESH: Risk Assessmentc-FosMESH : Coronary Angiography0302 clinical medicineMESH : Genetic MarkersProspective StudiesMESH: Coronary Artery DiseaseAged 80 and over0303 health sciencesMESH: Middle AgedGenes fosMESH: Smoking Cessation3. Good healthMESH : SmokingMESH: Myocardial InfarctionOsteosarcomaSmoking statusCardiology and Cardiovascular MedicineGenetic Markersmedicine.medical_specialtyRisk AssessmentMESH: Leukocytes03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedRNA MessengerMESH : Coronary Artery DiseaseRisk factorMESH : Aged 80 and overAgedChi-Square DistributionMESH: HumansMESH : Chi-Square DistributionMESH : Smoking CessationMESH : Humansmedicine.diseaseMESH: Coronary AngiographyLinear ModelsMESH: FemaleBlood leukocyte transcriptomeMESH : Genes fos030204 cardiovascular system & hematologyMESH: Genetic MarkersBioinformaticsCoronary AngiographyCoronary artery diseaseMESH: Linear ModelsCoronary artery diseaseMESH: Aged 80 and overRisk FactorsMESH: Risk FactorsMESH : Linear ModelsLeukocytesMESH : FemaleMESH : Risk AssessmentMESH: Agedc-FosbiologySmoking[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMiddle AgedMESH : Risk Factors[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemCardiologyFemaleFrancemedicine.symptomInflammation MediatorsMESH: SmokingMESH : MaleMESH: Inflammation MediatorsInflammationMESH: Genes fosMESH: Multivariate AnalysisMESH : Inflammation MediatorsInternal medicinemedicineIn patientMESH : France030304 developmental biologyMESH: RNA Messengerbusiness.industryMESH : Multivariate AnalysisMESH: MaleMESH: Prospective StudiesMESH: FranceMultivariate Analysisbiology.proteinSmoking CessationMESH : Myocardial Infarctionbusiness
researchProduct

Effects of chronic nicotine on the temporal structure of anxiety-related behavior in rats tested in hole-board.

2019

Abstract The present study aimed to assess the behavioral effects of chronic treatments of different doses of nicotine by using both quantitative and multivariate T-pattern analysis (TPA), which can reveal hidden behavioral structures, in Sprague-Dawley rats tested in the hole-board apparatus. To this purpose, nicotine ditartrate was administered at the doses of 0.1, 0.5 and 1 mg/kg i.p., three times per day, for 14 consecutive days. As to quantitative evaluations, we observed significant reductions in the mean durations and mean frequencies of walking, climbing, immobile-sniffing and rearing in comparison to control. A significant reduction of edge-sniff and head-dip mean frequencies was a…

MaleNicotineTime FactorsHole-boardmedicine.medical_treatmentQuantitative EvaluationsPhysiologyAnxietyMotor ActivityT-pattern analysisSettore BIO/09 - FisiologiaAnxiety; Chronic nicotine; Hole-board; Sprague-Dawley rats; T-pattern analysis; Animals; Anxiety; Dose-Response Relationship Drug; Drug Administration Schedule; Exploratory Behavior; Male; Motor Activity; Nicotine; Random Allocation; Rats; Rats Sprague-Dawley; Time FactorsDrug Administration ScheduleNicotineDose-Response RelationshipRats Sprague-Dawley03 medical and health sciencesSprague-Dawley ratRandom Allocation0302 clinical medicineSprague dawley ratsMedicineAnimalsBiological PsychiatryPharmacologyDose-Response Relationship Drugbusiness.industrySprague-Dawley rats030227 psychiatryRatsChronic nicotineChronic nicotineExploratory BehaviorSmoking cessationAnxietySprague-Dawleymedicine.symptomDrugbusinessmedicine.drugProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Maternal post-natal tobacco use and current parental tobacco use is associated with higher body mass index in children and adolescents: an internatio…

2015

Background: We investigated whether maternal smoking in the first year of life or any current parental smoking is associated with childhood or adolescent body mass index (BMI). Methods: Secondary analysis of data from a multi-centre, multi-country, cross-sectional study (ISAAC Phase Three). Parents/guardians of children aged 6-7 years completed questionnaires about their children's current height and weight, whether their mother smoked in the first year of the child's life and current smoking habits of both parents. Adolescents aged 13-14 years completed questionnaires about their height, weight and current parental smoking habits. A general linear mixed model was used to determine the asso…

MaleParentsPediatricsmedicine.medical_specialtyPediatric ObesityAdolescentCross-sectional studymedicine.medical_treatmentParental smokingOverweighttabaquismeBMImedicineHumansObesityPediatrics Perinatology and Child HealthadolescentsChildtabac efectes fisiològicsBody mass indexparesbusiness.industryinfantsConfoundingSmokingOverweightmedicine.diseaseObesityClinical trialTobacco useCross-Sectional StudiesInternationalPediatrics Perinatology and Child HealthSmoking cessationObservational studyFemalemedicine.symptombusinessBody mass indexobesitatResearch ArticleDemographytrastorns de la nutrició en els infants
researchProduct

Changes in parental smoking during pregnancy and risks of adverse birth outcomes and childhood overweight in Europe and North America

2020

Background Fetal smoke exposure is a common and key avoidable risk factor for birth complications and seems to influence later risk of overweight. It is unclear whether this increased risk is also present if mothers smoke during the first trimester only or reduce the number of cigarettes during pregnancy, or when only fathers smoke. We aimed to assess the associations of parental smoking during pregnancy, specifically of quitting or reducing smoking and maternal and paternal smoking combined, with preterm birth, small size for gestational age, and childhood overweight. Methods and findings We performed an individual participant data meta-analysis among 229,158 families from 28 pregnancy/bir…

MaleParentsembarazoEpidemiologyMaternal HealthSocial SciencesCHILDREN0302 clinical medicinePregnancynacimiento prematuroSmoking/adverse effectsPsychologyMATERNAL SMOKINGestudios de cohortesBody mass indexeducation.field_of_studyGeneral MedicineASSOCIATION16. Peace & justice3. Good healthPrenatal Exposure Delayed EffectsMedicineGROWTHefectos diferidos por exposición prenatalCohort studyHumanPRETERM BIRTHEurope/epidemiology03 medical and health sciencesHumansSmoking habitsRisk factoreducationBehaviorPregnancyBiology and Life SciencesInfantOdds ratiohábito de fumarmedicine.diseasePregnancy ComplicationsCESSATIONDemographyPediatric ObesityPhysiologyhumanos030204 cardiovascular system & hematologyOverweightNorth America/epidemiologyCohort StudiesHabitsRisk FactorsMedicine and Health Sciences030212 general & internal medicineDNA METHYLATIONSmokingRObstetrics and GynecologyGestational ageedad gestacionalPrenatal Exposure Delayed Effects/diagnosis3142 Public health care science environmental and occupational healthobesidad pediátricaPediatric Obesity/diagnosisEuropePhysiological ParametersCohort Studies; Europe; Female; Gestational Age; Humans; Infant Newborn; Male; North America; Pediatric Obesity; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors; Smoking; ParentsOBESITYPremature BirthFemalemedicine.symptomResearch ArticleBirth weightPopulationPremature Birth/diagnosisGestational AgepadresPrenatal Exposure Delayed EffectHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]All institutes and research themes of the Radboud University Medical CenterBirth weightmedicinefactores de riesgoEXPOSURElactantebusiness.industryRisk FactorBody WeightInfant NewbornOverweightNewbornReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Medical risk factors3121 General medicine internal medicine and other clinical medicineNorth AmericaBirthWomen's HealthWEIGHTCohort Studiebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyPLOS Medicine
researchProduct

The impact of chronic daily nicotine exposure and its overnight withdrawal on the structure of anxiety-related behaviors in rats: Role of the lateral…

2021

Tobacco smoking is a serious health problem worldwide and a leading cause of mortality. Nicotine, the addictive component of tobacco, affects a range of emotional responses, including anxiety-related behaviors. Although perceived by smokers to be anxiolytic, evidence suggests that smoking increases anxiety and that mood fluctuates with nicotine intake. Thus, nicotine addiction may depend on easing the psychobiological distress caused by its abuse. The lateral habenula (LHb) has been implicated as a neural substrate for acute nicotine-induced anxiety, but its role in anxiety-like behaviors associated with chronic nicotine exposure has not been explored. Here, we assessed the effect of chroni…

MaleSerotoninNicotinemedicine.drug_classmedia_common.quotation_subjectmedicine.medical_treatmentPhysiologyAnxietyT-pattern analysisSettore BIO/09 - FisiologiaAnxiolyticNicotineRats Sprague-Dawley03 medical and health sciences0302 clinical medicineBehavior; Rats; Serotonin; T-pattern analysis; Withdrawal symptomsmedicineAnimalsBiological Psychiatrymedia_commonPharmacologyNeuronsBehaviorHabenulaWithdrawal symptombusiness.industryAddictionT-pattern analysimedicine.disease030227 psychiatryRatsSubstance Withdrawal SyndromeNicotine withdrawalMoodAnxiogenicExploratory BehaviorRatSmoking cessationAnxietyWithdrawal symptomsmedicine.symptombusinessmedicine.drugProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Characteristics of patients seeking outpatient smoking cessation treatment before and after the implementation of a smoke-free law in Valencia (Spain…

2020

ObjectiveExplore potential changes in the characteristics of patients requesting smoking cessation treatment at an outpatient setting in Spain before and after Law 42/2010 was enacted.DesignThis is a cross-sectional study with convenience sampling. The information was obtained from the medical records of patients receiving smoking cessation treatment from January 2008 to December 2014.SettingHospital Clinico Universitario de Valencia.Participants423 patients who sought smoking cessation treatment 36 months before or 48 months after the enactment of the law.ResultsAfter the enactment of a comprehensive smoke-free law in Spain, the patients seeking smoking cessation treatment were older (p=0.…

Malemedicine.medical_specialtyCross-sectional studymedicine.medical_treatmentPsychological interventionlcsh:Medicineprimary careOutpatientsEpidemiologymedicineHumans15061704Health policybusiness.industryMedical recordPublic healthpublic healthlcsh:Rhealth policyGeneral MedicineIndividual levelCross-Sectional StudiesSpainLawSmoking cessationepidemiologyFemaleSmoking CessationHealth Services ResearchbusinessDelivery of Health CareBMJ Open
researchProduct

Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers

2011

Several studies have provided evidence for associations of polymorphisms located in and near dopamine-related genes and nicotine dependence and other smoking-related phenotypes, including pharmacogenetic interactions. Aim: The purpose of the present work was to examine the association of SNPs in the DOPA decarboxylase (DDC), dopamine receptor D2 (DRD2) and dopamine transporter (SLC6A3) genes with smoking cessation in a large retrospective study featuring approximately 900 cessation events. Materials & methods: Data originated from the enrollment questionnaire of the epidemiological ESTHER study of community-dwelling adults aged 50–74 years, conducted in the German state of Saarland bet…

Malemedicine.medical_specialtyGenotypeDopaminemedicine.medical_treatmentmedia_common.quotation_subjectPharmacologyPolymorphism Single NucleotideLinkage DisequilibriumCohort StudiesGermanyDopamine receptor D2Internal medicineEpidemiologyGeneticsmedicineHumansAge of OnsetSurvival analysisAgedmedia_commonDopamine transporterPharmacologyNorepinephrine Plasma Membrane Transport ProteinsbiologyReceptors Dopamine D2business.industryAddictionSmokingTobacco Use DisorderMiddle AgedAbstinenceSurvival AnalysisDopa Decarboxylasebiology.proteinEducational StatusMolecular MedicineSmoking cessationFemaleSmoking CessationbusinessPharmacogeneticsPharmacogenomics
researchProduct